United States (US) Oncology-Cancer Drugs Market (2025-2031) | Trends, Size & Revenue, Forecast, Outlook, Industry, Share, Analysis, Segmentation, Competitive Landscape, Growth, Companies, Value

Market Forecast By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Other Cancers) And Competitive Landscape
Product Code: ETC9972040 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Oncology-Cancer Drugs Market Outlook
  • Market Size of United States (US) Oncology-Cancer Drugs Market, 2024
  • Forecast of United States (US) Oncology-Cancer Drugs Market, 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Revenues & Volume for the Period 2021- 2031
  • United States (US) Oncology-Cancer Drugs Market Trend Evolution
  • United States (US) Oncology-Cancer Drugs Market Drivers and Challenges
  • United States (US) Oncology-Cancer Drugs Price Trends
  • United States (US) Oncology-Cancer Drugs Porter's Five Forces
  • United States (US) Oncology-Cancer Drugs Industry Life Cycle
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Targeted Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Immunotherapy (Biologic Therapy) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Hormonal Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Stomach Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Esophagus Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Other Cancers for the Period 2021- 2031
  • United States (US) Oncology-Cancer Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Indication
  • United States (US) Oncology-Cancer Drugs Top Companies Market Share
  • United States (US) Oncology-Cancer Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Oncology-Cancer Drugs Company Profiles
  • United States (US) Oncology-Cancer Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Oncology-Cancer Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Oncology-Cancer Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Oncology-Cancer Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oncology-Cancer Drugs Market - Industry Life Cycle

3.4 United States (US) Oncology-Cancer Drugs Market - Porter's Five Forces

3.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 United States (US) Oncology-Cancer Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the US

4.2.2 Technological advancements in oncology drug development

4.2.3 Growing investments in research and development for cancer treatments

4.3 Market Restraints

4.3.1 Stringent regulatory approvals for oncology drugs

4.3.2 High cost associated with cancer drug development and treatment

4.3.3 Growing competition among pharmaceutical companies in the oncology market

5 United States (US) Oncology-Cancer Drugs Market Trends

6 United States (US) Oncology-Cancer Drugs Market, By Types

6.1 United States (US) Oncology-Cancer Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.4 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F

6.1.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F

6.2 United States (US) Oncology-Cancer Drugs Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.3 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F

6.2.4 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.7 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.8 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

6.2.9 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

7 United States (US) Oncology-Cancer Drugs Market Import-Export Trade Statistics

7.1 United States (US) Oncology-Cancer Drugs Market Export to Major Countries

7.2 United States (US) Oncology-Cancer Drugs Market Imports from Major Countries

8 United States (US) Oncology-Cancer Drugs Market Key Performance Indicators

8.1 Patient survival rates post-treatment

8.2 Adoption rates of innovative cancer therapies

8.3 Number of clinical trials for cancer drugs in the US

9 United States (US) Oncology-Cancer Drugs Market - Opportunity Assessment

9.1 United States (US) Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

10 United States (US) Oncology-Cancer Drugs Market - Competitive Landscape

10.1 United States (US) Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All